Lawmaker Targets Inversions As Pfizer Mulls Allergan Deal
A U.S. representative unveiled legislation Monday targeting inversion transactions, taking aim at two corporate tax loopholes that earlier political backlash surrounding the tax-motivated deal structure failed to address amid renewed scrutiny...To view the full article, register now.
Already a subscriber? Click here to view full article